
Eric Olson
Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1623, 1693 |
| Total Applications | 1700 |
| Issued Applications | 960 |
| Pending Applications | 118 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16341596
[patent_doc_number] => 20200306246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => LOW-DOSE TRIPLE COMBINATION FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/364063
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16364063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/364063 | Low-dose triple combination formulation | Mar 24, 2019 | Issued |
Array
(
[id] => 16657379
[patent_doc_number] => 20210054015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => 3'',5''-DIMETHOXYBENZOYL-3'-AMINO-3'-DEOXYADENOSINE-5'-TRIPHOSPHATES AND PHARMACEUTICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/981242
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981242 | 3'',5''-dimethoxybenzoyl-3'-amino-3'-deoxy adenosine-5'-triphosphates and pharmaceutical uses thereof | Mar 13, 2019 | Issued |
Array
(
[id] => 14529979
[patent_doc_number] => 20190200610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/295087
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295087 | Pest control composition including novel iminopyridine derivative | Mar 6, 2019 | Issued |
Array
(
[id] => 16460805
[patent_doc_number] => 10844140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Phosphonated polysaccharides and gels and process for making same
[patent_app_type] => utility
[patent_app_number] => 16/294021
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7418
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/294021 | Phosphonated polysaccharides and gels and process for making same | Mar 5, 2019 | Issued |
Array
(
[id] => 15321003
[patent_doc_number] => 20200000831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/293140
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293140 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | Mar 4, 2019 | Abandoned |
Array
(
[id] => 16468167
[patent_doc_number] => 20200369704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => IMMUNOGENIC TREHALOSE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/970753
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970753 | Immunogenic trehalose compounds and uses thereof | Feb 28, 2019 | Issued |
Array
(
[id] => 14498153
[patent_doc_number] => 20190192731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/288576
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288576 | METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL | Feb 27, 2019 | Abandoned |
Array
(
[id] => 14806207
[patent_doc_number] => 20190269713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/289288
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289288
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289288 | Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides | Feb 27, 2019 | Issued |
| 16/289522 | 5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof | Feb 27, 2019 | |
Array
(
[id] => 16925262
[patent_doc_number] => 11046724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
[patent_app_type] => utility
[patent_app_number] => 16/285634
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 38308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285634 | Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells | Feb 25, 2019 | Issued |
Array
(
[id] => 14930481
[patent_doc_number] => 20190300878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/284393
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284393 | METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT | Feb 24, 2019 | Abandoned |
Array
(
[id] => 16621586
[patent_doc_number] => 20210040239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => IMPROVED PROCESS FOR THE PREPARATION OF DALTEPARIN SODIUM
[patent_app_type] => utility
[patent_app_number] => 16/968201
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968201 | Process for the preparation of Dalteparin sodium | Feb 13, 2019 | Issued |
Array
(
[id] => 17088618
[patent_doc_number] => 11116788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Compositions comprising sulfated polysaccharides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/273181
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12747
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16273181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/273181 | Compositions comprising sulfated polysaccharides and uses thereof | Feb 11, 2019 | Issued |
Array
(
[id] => 16141527
[patent_doc_number] => 10703826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/271735
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17242
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16271735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/271735 | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof | Feb 7, 2019 | Issued |
Array
(
[id] => 16946580
[patent_doc_number] => 20210205271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => MEBENDAZOLE PRODRUGS WITH ENHANCED SOLUBILITY AND ORAL BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 16/967924
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 412
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967924
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967924 | Mebendazole prodrugs with enhanced solubility and oral bioavailability | Feb 7, 2019 | Issued |
Array
(
[id] => 15083415
[patent_doc_number] => 20190336518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/263707
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/263707 | Compositions and methods for treating an aggregation disease or disorder | Jan 30, 2019 | Issued |
Array
(
[id] => 16881857
[patent_doc_number] => 11032021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Treatment for improving the use of dietary sugar for energy purposes
[patent_app_type] => utility
[patent_app_number] => 16/259155
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 11700
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16259155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/259155 | Treatment for improving the use of dietary sugar for energy purposes | Jan 27, 2019 | Issued |
Array
(
[id] => 16619970
[patent_doc_number] => 20210038623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => The use of Pulsatilla chinensis extract in the preparation of drugs for treatment of viral and/or bacterial diseases
[patent_app_type] => utility
[patent_app_number] => 16/966857
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966857
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966857 | Use of | Jan 24, 2019 | Issued |
Array
(
[id] => 16655996
[patent_doc_number] => 20210052632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => SELECTIVE PARP1 INHIBITORS TO TREAT CANCER
[patent_app_type] => utility
[patent_app_number] => 16/959519
[patent_app_country] => US
[patent_app_date] => 2019-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959519 | SELECTIVE PARP1 INHIBITORS TO TREAT CANCER | Jan 15, 2019 | Abandoned |
Array
(
[id] => 17967042
[patent_doc_number] => 11484547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Compositions and methods for cholesterol, glucose and microbiome control
[patent_app_type] => utility
[patent_app_number] => 16/241609
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6581
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241609 | Compositions and methods for cholesterol, glucose and microbiome control | Jan 6, 2019 | Issued |